PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

18 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Hüper, L.* et al.: Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers. Alzheimers Dement., DOI: 10.1002/alz.13863 (2024)
2.
Pandey, R.S.* et al.: Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.13851 (2024)
3.
Telpoukhovskaia, M.A.* et al.: New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshop. Alzheimers Dement. 10:e12458 (2024)
4.
Batra, R.* et al.: The landscape of metabolic brain alterations in Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.12714 (2022)
5.
Labus, J.S.* et al.: Interactions between brain and bile acid ratio profiles predict baseline cognitive status. Alzheimers Dement. 18:e067272 (2022)
6.
Oeckl, P.* et al.: Relationship of serum beta-synuclein with blood biomarkers and brain atrophy. Alzheimers Dement. 19, 1358-1371 (2022)
7.
van Duijn, C.M.* et al.: Interplay of the human exposome, metabolome and gut microbiome in dementia and major depression. Alzheimers Dement. 18:e067261 (2022)
8.
Wang, T.* et al.: APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimers Dement. 18, 2151-2166 (2022)
9.
Wörheide, M. ; Krumsiek, J.* ; Kastenmüller, G. ; Kaddurah-Daouk, R.F.* & Arnold, M.: A proof of concept study towards multi-omics-based computational drug repositioning in Alzheimer's disease. Alzheimers Dement. 17, 3:e056673 (2022)
10.
Baloni, P.* et al.: Investigating the importance of acylcarnitines in Alzheimer's disease. Alzheimers Dement. 17:e056647 (2021)
11.
Horgusluoglu, E.* et al.: Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease. Alzheimers Dement., DOI: 10.1002/alz.12468 (2021)
12.
Chandupatla, R.R.* ; Flatley, A. ; Feederle, R. ; Mandelkow, E.M.* & Kaniyappan, S.*: Novel antibody against low-n oligomers of tau protein promotes clearance of tau in cells via lysosomes. Alzheimers Dement. 6:e12097 (2020)
13.
Kling, M.A.* et al.: Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau. Alzheimers Dement. 16, 1234-1247 (2020)
14.
Barupal, D.K.* et al.: Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology. Alzheimers Dement. 11, 619-627 (2019)
15.
Nho, K.* et al.: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement. 15, 232-244 (2019)
16.
MahmoudianDehkordi, S.* et al.: Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement. 15, 76-92 (2018)
17.
Ovsepian, S.V. ; O'Leary, V.B. ; Zaborszky, L.* ; Ntziachristos, V. & Dolly, O.J.*: Synaptic vesicle cycle and amyloid beta: Biting the hand that feeds. Alzheimers Dement. 14, 502-513 (2018)
18.
Toledo, J.B.* et al.: Metabolic network failures in Alzheimer's disease-A biochemical road map. Alzheimers Dement. 13, 965-984 (2017)
▮◀ ◀◀ ▶▶ ▶▮